Expression of p16 and p53 proteins in cervical cancer cases in a tertiary centre in Ghana: an immunohistochemical study
Babatunde Moses Duduyemi, Betty Nkansah Osei Mensah, Ebenezer Kojo Addae, Lorraine Sallah, Kweku Bedu-Addo · 2026
Read Expression of p16 and p53 proteins in cervical cancer cases in a tertiary centre in Ghana: an immunohistochemical study by Babatunde Moses Duduyemi, Betty Nkansah Osei Mensah, Ebenezer Kojo Addae, Lorraine Sallah, Kweku Bedu-Addo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13393724.txt.
Description
Babatunde Moses Duduyemi and coauthors test two protein markers in cervical cancer cases from a Ghanaian tertiary center in a 2026 immunohistochemical study. Cervical cancer remains a major public health problem in Ghana, where screening is limited and many cases arrive late.
The retrospective study examined 135 archived tissue samples from Kumasi, staining them for p16 and p53 and linking results to age, tumor type, and grade. Most cases were squamous cell carcinoma, and about half were poorly differentiated. The work weighs whether p16 staining can stand in for HPV testing and what p53 adds to prognosis.
Catalog record
| CREATOR | Babatunde Moses Duduyemi, Betty Nkansah Osei Mensah, Ebenezer Kojo Addae, Lorraine Sallah, Kweku Bedu-Addo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |